Correlation Between Todos Medical and Xylo Technologies
Can any of the company-specific risk be diversified away by investing in both Todos Medical and Xylo Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Todos Medical and Xylo Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Todos Medical and Xylo Technologies, you can compare the effects of market volatilities on Todos Medical and Xylo Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Todos Medical with a short position of Xylo Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Todos Medical and Xylo Technologies.
Diversification Opportunities for Todos Medical and Xylo Technologies
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Todos and Xylo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Todos Medical and Xylo Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xylo Technologies and Todos Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Todos Medical are associated (or correlated) with Xylo Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xylo Technologies has no effect on the direction of Todos Medical i.e., Todos Medical and Xylo Technologies go up and down completely randomly.
Pair Corralation between Todos Medical and Xylo Technologies
If you would invest 0.00 in Todos Medical on April 25, 2025 and sell it today you would earn a total of 0.00 from holding Todos Medical or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Todos Medical vs. Xylo Technologies
Performance |
| Timeline |
| Todos Medical |
| Xylo Technologies |
Todos Medical and Xylo Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Todos Medical and Xylo Technologies
The main advantage of trading using opposite Todos Medical and Xylo Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Todos Medical position performs unexpectedly, Xylo Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xylo Technologies will offset losses from the drop in Xylo Technologies' long position.| Todos Medical vs. Rushnet | Todos Medical vs. Applied DNA Sciences | Todos Medical vs. RadNet Inc | Todos Medical vs. TPT Global Tech |
| Xylo Technologies vs. Bone Biologics Corp | Xylo Technologies vs. NanoVibronix | Xylo Technologies vs. Bluejay Diagnostics | Xylo Technologies vs. Vivos Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |